BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 593947)

  • 1. [Blood serum concentration and urinary excretion of myoinositol in patients with malignant tumors].
    Trznadel K; Walasek L; Lutz W; Nagański T; Fajndt S
    Pol Tyg Lek; 1977 Nov; 32(46):1785-7. PubMed ID: 593947
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of glucagon on myoinositol levels in the blood serum and its excretion with urine.
    Markiewicz K; Lutz W; Cholewa M
    Acta Physiol Pol; 1978; 29(5):475-9. PubMed ID: 747110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between serum myoinositol and serum lipid concentrations in patients with chronic renal failure].
    Trznadel K; Walasek L; Lutz W
    Pol Tyg Lek; 1977 Apr; 32(14):531-4. PubMed ID: 854467
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myoinositol levels in the serum and urine of healthy children].
    Bednorz R
    Pediatr Pol; 1985 Sep; 60(9):647-51. PubMed ID: 3831897
    [No Abstract]   [Full Text] [Related]  

  • 5. [Simple method of quantitative determination of myoinositol in the serum and urine].
    Lutz W; Trznadel K; Walasek L
    Pol Tyg Lek; 1976 May; 31(17):711-3. PubMed ID: 934940
    [No Abstract]   [Full Text] [Related]  

  • 6. The dynamics of serum myoinositol concentration changes during haemodialysis and peritoneal dialysis.
    Trznadel K; Walasek L; Waldemar L
    Acta Med Pol; 1977; 18(1):55-61. PubMed ID: 855681
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of increased serum myoinositol levels.
    Melmed S; Bank H; Lewin LM
    Isr J Med Sci; 1974 Dec; 10(12):1518-22. PubMed ID: 4140854
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum myoinositol and phosphatidylinositol in patients with viral hepatitis].
    Tkaczewski W; Tkacz B; Lutz W; Szeszko A; Dworniak D; Drobnik S
    Pol Tyg Lek; 1977 Dec; 32(49):1913-5. PubMed ID: 604964
    [No Abstract]   [Full Text] [Related]  

  • 9. Accumulation of myoinositol in plasma and red cells of diabetic patients.
    Servo C
    Acta Med Scand; 1977 Jan; 201(1-2):59-62. PubMed ID: 835372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-inflammatory action of myoinositol in renal insufficiency].
    Rysz J; Bartnicki P; Błaszczak R; Kujawski K; Ciałkowska-Rysz A; Olszewski R; Markuszewski L
    Pol Merkur Lekarski; 2006 Feb; 20(116):180-3. PubMed ID: 16708635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary polyamines before and after treatment of malignant tumors].
    Martinović S; Filipović D
    Srp Arh Celok Lek; 1989; 117(7-8):465-71. PubMed ID: 2595471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [NMR-relaxation of blood serum in cancer patients].
    Papish EA; Temkina TIa; Kariakina NF
    Med Radiol (Mosk); 1988 Aug; 33(8):47-50. PubMed ID: 3412139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary excretion of tetracycline (tetracontrol of excretion) in cancer patients. An early diagnostic test?].
    Romero Roldan JM
    Rev Sanid Hig Publica (Madr); 1976; 50(7-8):671-700. PubMed ID: 1027083
    [No Abstract]   [Full Text] [Related]  

  • 14. Sorbitol and myoinositol levels in the cerebrospinal fluid of diabetic patients.
    Servo C
    Acta Endocrinol Suppl (Copenh); 1980; 238():133-7. PubMed ID: 6933810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kimbarowski's color precipitation reaction and Parri's reaction in patients with malignant neoplasms].
    Ciencialowa M; Pajakowa E
    Pol Tyg Lek; 1972 Dec; 27(52):2054-7. PubMed ID: 4651854
    [No Abstract]   [Full Text] [Related]  

  • 16. [Citrate values in the whole blood of patients with malignant tumors of various locations].
    Schaur RJ; Georgiopulos E; Fink E; Kronberger L; Schauenstein E
    Med Klin; 1976 May; 71(21):900-3. PubMed ID: 933983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of pterins in tumor-bearing patients.
    Andrysek O; Gregora V
    Neoplasma; 1983; 30(4):497-507. PubMed ID: 6888612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary excretion of asparagne and aspartate in control subjects and patients with cancer before and after treatment with K-Mg-aspartate].
    Kronberger L; Fink E; Daill M; Schindler R
    Wien Klin Wochenschr; 1972 Nov; 84(45):722-5. PubMed ID: 4641568
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of large doses of medroxyprogesterone acetate (MPA) on urinary estrogen levels and serum levels of cortisol T4 LH and testosterone in patients with advanced cancer.
    Sadoff L; Lusk W
    Obstet Gynecol; 1974 Feb; 43(2):262-7. PubMed ID: 4359078
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma and urinary dehydroepiandrosterone in cancer.
    Sonka J; Vítková M; Gregorová I; Tomsová Z; Hilgertová J; Staś J
    Endokrinologie; 1973 Aug; 62(1):61-8. PubMed ID: 4274190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.